Prophylactic effects of hydroxychloroquine on the incidence of COVID-19 in patients with rheumatic arthritis: an observational cohort study
Naderi et al.,
Prophylactic effects of hydroxychloroquine on the incidence of COVID-19 in patients with rheumatic arthritis:..,
Immunopathologia Persa, doi:10.34172/ipp.2021.29 (Preprint)
Prospective observational study of 215 RA patients treated with HCQ showing 9 cases, 1 hospitalization (without ICU/intubation), and no mortality.
Naderi et al., 31 Jan 2021, preprint, 7 authors.
Abstract: See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/350855140
Prophylactic effects of hydroxychloroquine on the incidence of COVID-19 in
patients with rheumatic arthritis: an observational cohort study
Article in Immunopathologia Persa · April 2021
DOI: 10.34172/ipp.2021.29
CITATIONS
READS
0
109
7 authors, including:
Zohre Naderi
Ziba Farajzadegan
Isfahan University of Medical Sciences
Isfahan University of Medical Sciences
13 PUBLICATIONS 164 CITATIONS
216 PUBLICATIONS 2,183 CITATIONS
SEE PROFILE
SEE PROFILE
Ramin Sami
Mansour Salesi
Isfahan University of Medical Sciences
Isfahan University of Medical Sciences
36 PUBLICATIONS 147 CITATIONS
54 PUBLICATIONS 648 CITATIONS
SEE PROFILE
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
Frequency of positional obstructive sleep apnea (POSA) in patients with obstructive sleep apnea and differences in demographic and clinical characteristics View
project
Compliance with continuous positive airway pressure in Persian patients with obstructive sleep apnea View project
All content following this page was uploaded by Zohre Naderi on 14 April 2021.
The user has requested enhancement of the
Original
Immunopathol Persa. 2021;7(2):e29
http www.immunopathol.com
Immunopathologia Persa
DOI:10.34172/ipp.2021.29
Prophylactic effects of hydroxychloroquine on the
incidence of COVID-19 in patients with rheumatic
arthritis: an observational cohort study
ID
ID
ID
ID
ID
ID
Zohre Naderi1 , Bahar Sadeghi2 , Ziba Farajzadegan3 , Ramin Sami1 , Mansour Salesi1* , Vahid Mansouri4* ,
ID
Babak Amra5
Department of Internal Medicine, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Student Research Committee, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3
Department of Community Medicine, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
4
Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
5
Bamdad Respiratory and Sleep Research Center, Pulmonary and Sleep Ward, Internal Medicine Department, Isfahan University of
Medical Sciences, Isfahan, Iran
1
2
*Correspondence to
Mansour Salesi,
Email: Salesi@med.mui.ac.ir;
Vahid Mansouri,
Email: Mansoury.vahid@gmail.
com
Received 2 Jan 2021
Accepted 28 Feb. 2020
Published online 6 Apr. 2021
Keywords: COVID-19,
Hydroxychloroquine,
Prophylaxis, Rheumatic
arthritis, Observational,
Prospective
Citation: Naderi Z,
Sadeghi B, Farajzadegan
Z, Sami R, Salesi M,
Mansouri V, Amra B.
Prophylactic effects of
hydroxychloroquine
on the incidence of
COVID-19 in patients
with rheumatic arthritis:
an observational cohort
study. Immunopathol
Persa. 2021;7(2):e29.
DOI:10.34172/
ipp.2021.29.
Abstract
Introduction: Rheumatoid arthritis (RA) is a systemic autoimmune disease with substantial morbidity and mortality.
Anti-malarial drugs like hydroxychloroquine are indicated in several rheumatic diseases such as RA. Some reports
have suggested hydroxychloroquine for prevention of COVID-19.
Objectives: Whether hydroxychloroquine has prophylactic effects for COVID-19 in rheumatic patients.
Patients and Methods: In this multicenter cohort-based observational study the preventive effect of
hydroxychloroquine regarding the incidence and severity of COVID-19 was investigated in patients with RA who
referred to..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit